Cutler Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $14K | Sell |
400
-9,100
| -96% | -$1.24M | ﹤0.01% | 1145 |
|
|
2023
Q4 | $217K | Buy |
9,500
+6,500
| +217% | +$793K | 0.02% | 695 |
|
|
2023
Q3 | $25K | Sell |
3,000
-5,600
| -65% | -$712K | ﹤0.01% | 1879 |
|
|
2023
Q2 | $24K | Buy |
8,600
+1,800
| +26% | +$234K | ﹤0.01% | 1747 |
|
|
2023
Q1 | $23K | Sell |
6,800
-80,200
| -92% | -$10.5M | ﹤0.01% | 1840 |
|
|
2022
Q4 | $197K | Sell |
87,000
-15,400
| -15% | -$1.99M | 0.02% | 792 |
|
|
2022
Q3 | $156K | Buy |
102,400
+7,100
| +7% | +$882K | 0.01% | 1105 |
|
|
2022
Q2 | $221K | Buy |
95,300
+3,200
| +3% | +$380K | 0.02% | 943 |
|
|
2022
Q1 | $132K | Sell |
92,100
-90,000
| -49% | -$11.7M | 0.01% | 1497 |
|
|
2021
Q4 | $481K | Buy |
182,100
+88,000
| +94% | +$13.6M | 0.02% | 770 |
|
|
2021
Q3 | $540K | Sell |
94,100
-138,800
| -60% | -$23.4M | 0.02% | 748 |
|
|
2021
Q2 | $1.39M | Buy |
232,900
+79,400
| +52% | +$12.2M | 0.06% | 330 |
|
|
2021
Q1 | $629K | Sell |
153,500
-39,200
| -20% | -$6.23M | 0.03% | 632 |
|
|
2020
Q4 | $901K | Buy |
192,700
+140,000
| +266% | +$20M | 0.04% | 428 |
|
|
2020
Q3 | $223K | Sell |
52,700
-73,700
| -58% | -$10M | 0.01% | 866 |
|
|
2020
Q2 | $1.09M | Buy |
126,400
+1,400
| +1% | +$178K | 0.07% | 278 |
|
|
2020
Q1 | $456K | Buy |
125,000
+53,600
| +75% | +$6.17M | 0.02% | 585 |
|
|
2019
Q4 | $488K | Sell |
71,400
-19,300
| -21% | -$2.15M | 0.03% | 458 |
|
|
2019
Q3 | $85K | Buy |
90,700
+43,800
| +93% | +$4.58M | 0.01% | 1174 |
|
|
2019
Q2 | $390K | Buy |
46,900
+33,800
| +258% | +$3.6M | 0.04% | 408 |
|
|
2019
Q1 | $38K | Sell |
13,100
-30,200
| -70% | -$3.31M | ﹤0.01% | 1608 |
|
|
2018
Q4 | $169K | Buy |
43,300
+1,200
| +3% | +$127K | 0.02% | 731 |
|
|
2018
Q3 | $713K | Sell |
42,100
-46,400
| -52% | -$5.46M | 0.05% | 366 |
|
|
2018
Q2 | $506K | Buy |
88,500
+10,500
| +13% | +$1.12M | 0.04% | 436 |
|
|
2018
Q1 | $531K | Sell |
78,000
-246,600
| -76% | -$27.3M | 0.05% | 398 |
|
|
2017
Q4 | $2.41M | Sell |
324,600
-299,100
| -48% | -$32M | 0.1% | 140 |
|
|
2017
Q3 | $5.31M | Sell |
623,700
-658,800
| -51% | -$70.4M | 0.2% | 72 |
|
|
2017
Q2 | $6.89M | Buy |
1,282,500
+457,800
| +56% | +$45.1M | 0.25% | 70 |
|
|
2017
Q1 | $2.98M | Sell |
824,700
-553,800
| -40% | -$53M | 0.12% | 145 |
|
|
2016
Q4 | $1.97M | Buy |
1,378,500
+386,400
| +39% | +$35.2M | 0.07% | 203 |
|
|
2016
Q3 | $2.91M | Sell |
992,100
-73,200
| -7% | -$6.96M | 0.13% | 116 |
|
|
2016
Q2 | $1.45M | Buy |
1,065,300
+328,200
| +45% | +$29.4M | 0.07% | 196 |
|
|
2016
Q1 | $892K | Sell |
737,100
-4,800
| -0.6% | -$429K | 0.06% | 301 |
|
|
2015
Q4 | $2.06M | Buy |
+741,900
| New | +$80.5M | 0.11% | 158 |
|
Other funds holding IBB
CB
Cutler Group's IBB Position: Q1 2024 in Review
Cutler Group sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 200 shares — an estimated $27.3K sold.
Cutler Group first reported a position in IBB in Q4 2015 and held it in 28 quarters. The position peaked at $17.2M in Q3 2016. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.
- Cutler Group reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 200 iShares Biotechnology ETF shares in Q1 2024, an estimated $27.3K.
- Cutler Group first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 28 quarters.
- Cutler Group's iShares Biotechnology ETF position peaked at $17.2M in Q3 2016.
- 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.